NewsPublic Affairs / February 12, 2018

Greenfield Waits For Eli Lilly And Co.'s Decision On Animal Health Business

Greenfield Waits For Eli Lilly And Co.'s Decision On Animal Health BusinessIf Eli Lilly and Co. officials were to sell or spin off Elanco Animal Health, there's no guarantee the operation would remain in the city.Eli Lilly and Co., Greenfield, Elanco Animal Health2018-02-12T00:00:00-05:00
Greenfield Waits For Eli Lilly And Co.'s Decision On Animal Health Business

Buildings along W. Main Street (U.S. 40) in downtown Greenfield, Indiana.

Nyttend/public domain

GREENFIELD, Ind. (AP) — Officials in Greenfield are awaiting a company's decision on whether it will sell or spin off its animal health business, a move that could deliver a blow to the local economy.

The Indianapolis Business Journal reports that if Eli Lilly and Co. officials were to sell or spin off Elanco Animal Health, there's no guarantee the operation would remain in Greenfield. The company has had a presence in the city since it built research laboratories in the late 19th century.

Elanco employs about 775 at its campus in Greenfield, a 21,000-person city about 15 miles east of Indianapolis.

Mayor Chuck Fewell says the city would hate to lose the business.

Lilly CEO David Ricks said last month that the company would likely announce a decision by July.

 

 

Related News

Affordable, Modular Housing Grant Seeks to Attract Workers
Technology Critical For Farmers Adapting To Climate Change, Says Panel
Auto Part Suppliers In Indiana Feel The Toll Of UAW's Strike On GM